David Rabin

Founder at

Apollo Neuroscience, Inc.

Consumer Services

Retail Trade

Finance

Profile

David Rabin is the founder of Apollo Neuroscience, Inc., founded in 2014, and holds the title of Director.
Former job includes Venture Partner at Noetic Psychedelic.
Education history includes an undergraduate degree from Rensselaer Polytechnic Institute conferred in 2007 and a doctorate from Albany Medical College conferred in 2013.

David Rabin active positions

Companies	Position	Start
Apollo Neuroscience, Inc. Apollo Neuroscience, Inc. Specialty StoresRetail Trade Sells wellness products through online	Founder	2013-12-31

All active positions of David Rabin

Former positions of David Rabin

Companies	Position	End
Noetic Psychedelic Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements.	Private Equity Investor	-

See the detail of David Rabin's experience

Training of David Rabin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Rabin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Rensselaer Polytechnic Institute Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Albany Medical College Albany Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Apollo Neuroscience, Inc. Apollo Neuroscience, Inc. Specialty StoresRetail Trade Sells wellness products through online	Retail Trade
Noetic Psychedelic Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements.	Finance